Current Ratio of Lineage Cell Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lineage Cell Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Lineage Cell Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 396%, a 60% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 396% +148% +60% 30 Sep 2025
Q2 2025 347% +92% +36% 30 Jun 2025
Q1 2025 313% +49% +19% 31 Mar 2025
Q4 2024 286% +18% +6.5% 31 Dec 2024
Q3 2024 248% -48% -16% 30 Sep 2024
Q2 2024 255% -48% -16% 30 Jun 2024
Q1 2024 264% -36% -12% 31 Mar 2024
Q4 2023 268% -43% -14% 31 Dec 2023
Q3 2023 296% +15% +5.3% 30 Sep 2023
Q2 2023 302% -16% -5% 30 Jun 2023
Q1 2023 300% -82% -21% 31 Mar 2023
Q4 2022 311% -145% -32% 31 Dec 2022
Q3 2022 281% -549% -66% 30 Sep 2022
Q2 2022 318% -443% -58% 30 Jun 2022
Q1 2022 382% -274% -42% 31 Mar 2022
Q4 2021 456% -151% -25% 31 Dec 2021
Q3 2021 830% +149% +22% 30 Sep 2021
Q2 2021 761% -41% -5.1% 30 Jun 2021
Q1 2021 656% -42% -6% 31 Mar 2021
Q4 2020 607% +25% +4.3% 31 Dec 2020
Q3 2020 681% +177% +35% 30 Sep 2020
Q2 2020 802% +356% +80% 30 Jun 2020
Q1 2020 698% +163% +31% 31 Mar 2020
Q4 2019 582% -44% -7.1% 31 Dec 2019
Q3 2019 504% -148% -23% 30 Sep 2019
Q2 2019 446% -110% -20% 30 Jun 2019
Q1 2019 535% +139% +35% 31 Mar 2019
Q4 2018 626% +284% +83% 31 Dec 2018
Q3 2018 652% +373% +134% 30 Sep 2018
Q2 2018 556% +264% +90% 30 Jun 2018
Q1 2018 396% +33% +9.1% 31 Mar 2018
Q4 2017 342% +16% +5% 31 Dec 2017
Q3 2017 279% -71% -20% 30 Sep 2017
Q2 2017 292% -39% -12% 30 Jun 2017
Q1 2017 362% +31% +9.2% 31 Mar 2017
Q4 2016 326% -40% -11% 31 Dec 2016
Q3 2016 350% -31% -8.1% 30 Sep 2016
Q2 2016 332% -25% -7% 30 Jun 2016
Q1 2016 332% -11% -3.2% 31 Mar 2016
Q4 2015 366% +68% +23% 31 Dec 2015
Q3 2015 380% +185% +95% 30 Sep 2015
Q2 2015 357% +157% +78% 30 Jun 2015
Q1 2015 343% +139% +68% 31 Mar 2015
Q4 2014 298% +63% +27% 31 Dec 2014
Q3 2014 195% -70% -26% 30 Sep 2014
Q2 2014 200% -106% -35% 30 Jun 2014
Q1 2014 204% -109% -35% 31 Mar 2014
Q4 2013 235% -187% -44% 31 Dec 2013
Q3 2013 265% -373% -58% 30 Sep 2013
Q2 2013 306% -498% -62% 30 Jun 2013
Q1 2013 313% -600% -66% 31 Mar 2013
Q4 2012 422% 31 Dec 2012
Q3 2012 638% 30 Sep 2012
Q2 2012 804% 30 Jun 2012
Q1 2012 913% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.